V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220019104 | 220006575 | null | 37.2 | Palliative (P) | 2013-10-02 | 2013-10-31 | null | N | N | 220025166 | NOT MATCHED |
| 220019105 | 220006576 | 1.66 | 15.85 | Curative (C) | 2016-04-23 | 2016-06-06 | ATG + Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | N | N | 220025171 | NOT MATCHED |
| 220019106 | 220006577 | 1.88 | null | Disease modification (D) | 2015-07-31 | 2015-08-01 | Hydroxycarbamide | N | N | 220025174 | HYDROXYCARBAMIDE |
| 220019107 | 220013596 | null | 76.1 | Curative (C) | 2017-01-13 | 2017-01-13 | AML Relapsed FLA - DaunoXome | N | null | 220025180 | NOT MATCHED |
| 220019108 | 220006586 | null | null | Curative (C) | null | 2017-07-03 | APML Consolidation I ATRA,Cytarabine,Mitoxantrone | N | N | 220025218 | NOT MATCHED |
| 220019109 | 220006593 | null | 63 | null | 2015-03-25 | 2016-05-27 | Cytarabine Low Dose | N | N | 220025249 | CYTARABINE |
| 220019110 | 220006596 | 1.83 | 99.4 | Curative (C) | 2015-01-28 | 2015-02-11 | AML Downs HA | N | N | 220025304 | NOT MATCHED |
| 220019111 | 220006598 | 1.52 | 76.4 | Curative (C) | 2014-10-04 | 2015-01-06 | ALL Ph+ve Imatinib alone | N | N | 220025310 | NOT MATCHED |
| 220019112 | 220020782 | 1.75 | null | Palliative (P) | 2014-11-14 | 2015-03-21 | Hydroxycarbamide | N | N | 220025320 | HYDROXYCARBAMIDE |
| 220019113 | 220006600 | 0 | 68 | Disease modification (D) | 2017-02-21 | 2017-02-21 | CYTARABINE | 2 | N | 220025327 | CYTARABINE |
| 220019114 | 220006605 | 1.5 | 56.8 | Curative (C) | 2014-09-15 | 2014-09-21 | Hydroxycarbamide | 99 | N | 220025345 | HYDROXYCARBAMIDE |
| 220019115 | 220013612 | null | 71.5 | Palliative (P) | 2016-05-20 | 2016-05-20 | AML MyeChild 01 B Cytarabine/Daunoxome + GO | N | Y | 220025353 | NOT MATCHED |
| 220019116 | 220013615 | null | 64.7 | null | 2015-12-18 | 2016-02-08 | Hydroxycarbamide | Y | N | 220025361 | HYDROXYCARBAMIDE |
| 220019117 | 220006612 | 1.63 | null | Disease modification (D) | 2014-02-19 | 2014-05-15 | AML MyeChild 01 FLA-Idarubicin | N | N | 220025362 | NOT MATCHED |
| 220019118 | 220006613 | 0.96 | 64.3 | Palliative (P) | 2016-01-22 | 2016-01-22 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE | N | N | 220025362 | NOT MATCHED |
| 220019120 | 220013620 | 1.56 | null | Curative (C) | 2017-05-17 | 2017-05-19 | Cytarabine Intrathecal (any age) | null | N | 220025373 | CYTARABINE |
| 220019121 | 220013621 | null | 53 | Palliative (P) | 2017-05-26 | 2017-06-02 | BMT Fludarabine/Thiotepa/Treosulfan + ATG | Y | N | 220025384 | NOT MATCHED |
| 220019122 | 220006622 | null | 59.8 | null | 2017-03-01 | 2017-03-06 | Hydroxycarbamide | 02 | N | 220025386 | HYDROXYCARBAMIDE |
| 220019124 | 220013624 | null | 88 | Curative (C) | 2014-07-21 | 2014-07-21 | Hydroxycarbamide | 99 | N | 220025400 | HYDROXYCARBAMIDE |
| 220019125 | 220017430 | 1.72 | 74 | Palliative (P) | 2015-06-10 | 2015-06-10 | Hydroxycarbamide | 2 | null | 220025401 | HYDROXYCARBAMIDE |
| 220019126 | 220006631 | null | null | Curative (C) | 2015-05-31 | 2015-06-03 | Cytarabine low (10to20mg/m2) IV/SC | 2 | N | 220025417 | CYTARABINE |
| 220019127 | 220006635 | null | null | Palliative (P) | 2016-11-17 | 2016-11-17 | Cytarabine Low Dose | N | N | 220025424 | CYTARABINE |
| 220019128 | 220013629 | 1.63 | null | Curative (C) | 2015-10-20 | 2015-10-20 | AML Interim Guidelines FLA -Ida | null | N | 220025425 | NOT MATCHED |
| 220019129 | 220006638 | null | 87.1 | Curative (C) | 2017-03-08 | 2017-03-08 | CYTARABINE | N | null | 220025428 | CYTARABINE |
| 220019130 | 220006640 | 0 | 81.6 | Curative (C) | 2014-10-05 | 2014-12-18 | CYTARABINE | 99 | N | 220025439 | CYTARABINE |
| 220019131 | 220006645 | null | 52.5 | Curative (C) | 2016-05-21 | 2017-02-17 | Hydroxycarbamide | 2 | N | 220025472 | HYDROXYCARBAMIDE |
| 220019132 | 220006646 | 0 | 60.5 | Disease modification (D) | 2014-08-11 | 2014-10-20 | FBC Conditionining | Y | N | 220025474 | NOT MATCHED |
| 220019133 | 220013638 | 1.7 | 75.5 | Palliative (P) | 2018-03-26 | 2018-03-27 | Cytarabine Intrathecal (any age) | N | null | 220025481 | CYTARABINE |
| 220019135 | 220013640 | 1.51 | 79 | Curative (C) | null | 2015-12-06 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220025484 | CYTARABINE |
| 220019136 | 220017440 | 1.66 | 22.9 | Curative (C) | 2018-06-08 | 2018-06-26 | null | 2 | N | 220025487 | NOT MATCHED |
| 220019137 | 220006653 | null | null | Palliative (P) | 2016-12-15 | 2017-04-21 | Hydroxycarbamide | y | N | 220025491 | HYDROXYCARBAMIDE |
| 220019138 | 220006654 | null | 64.3 | Curative (C) | 2013-06-08 | 2013-08-22 | Cytarabine Low Dose | N | N | 220025496 | CYTARABINE |
| 220019139 | 220006654 | 1.75 | null | Palliative (P) | 2013-09-28 | 2013-11-14 | FBC Conditionining | 02 | N | 220025496 | NOT MATCHED |
| 220019140 | 220006659 | 1.67 | null | Curative (C) | 2014-02-26 | 2014-02-26 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220025521 | CYTARABINE |
| 220019141 | 220006661 | 1.68 | 69.5 | Disease modification (D) | 2018-06-19 | 2018-06-22 | Hydroxycarbamide | Y | N | 220025523 | HYDROXYCARBAMIDE |
| 220019143 | 220019569 | null | 55 | Disease modification (D) | 2014-01-21 | 2014-01-22 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220025532 | CYTARABINE |
| 220019144 | 220006666 | 0 | 78 | Palliative (P) | 2017-04-01 | 2017-04-01 | Hydroxycarbamide | N | N | 220025542 | HYDROXYCARBAMIDE |
| 220019145 | 220006668 | 1.74 | 0 | Palliative (P) | null | 2018-04-20 | Hydroxycarbamide | N | null | 220025586 | HYDROXYCARBAMIDE |
| 220019146 | 220006671 | 1.78 | 0 | Adjuvant (A) | 2017-09-29 | 2017-09-29 | Hydroxycarbamide | N | null | 220025591 | HYDROXYCARBAMIDE |
| 220019147 | 220006671 | 0 | 54 | Disease modification (D) | 2016-11-18 | 2017-03-20 | APML Consolidation I ATRA,Cytarabine,Mitoxantrone | N | N | 220025591 | NOT MATCHED |
| 220019148 | 220006673 | null | 71.1 | Adjuvant (A) | null | 2015-02-12 | Hydroxycarbamide | N | N | 220025607 | HYDROXYCARBAMIDE |
| 220019149 | 220006674 | 0 | 19.9 | Curative (C) | 2014-07-20 | 2014-07-21 | null | Y | N | 220025621 | NOT MATCHED |
| 220019151 | 220006678 | null | 61.2 | Disease modification (D) | 2017-08-11 | 2017-08-11 | Hydroxycarbamide | Y | null | 220025638 | HYDROXYCARBAMIDE |
| 220019152 | 220006680 | 1.8 | 76 | Disease modification (D) | 2015-02-23 | 2015-02-23 | CYTARABINE | Y | N | 220025645 | CYTARABINE |
| 220019154 | 220013667 | 1.78 | 96.1 | Curative (C) | 2019-02-05 | 2019-02-05 | Hydroxycarbamide | 02 | N | 220025668 | HYDROXYCARBAMIDE |
| 220019155 | 220006688 | null | 83.2 | Curative (C) | 2015-08-11 | 2015-08-11 | CYTARABINE | Y | N | 220025677 | CYTARABINE |
| 220019157 | 220006701 | null | 63 | null | 2014-07-03 | 2014-07-31 | Cytarabine low (10to20mg/m2) IV/SC | Y | N | 220025732 | CYTARABINE |
| 220019160 | 220006705 | 1.6 | null | Disease modification (D) | 2013-08-18 | 2013-08-22 | Hydroxycarbamide | N | N | 220025756 | HYDROXYCARBAMIDE |
| 220019161 | 220006707 | 0 | 35.8 | Palliative (P) | 2014-11-16 | 2015-02-18 | AML Interim Guidelines FLA -Ida | N | N | 220025764 | NOT MATCHED |
| 220019162 | 220006708 | null | 33.7 | Curative (C) | 2013-10-14 | 2013-10-14 | AML MyeChild 01 IT Cyt | N | N | 220025767 | NOT MATCHED |